About Intelliscend
Intelliscend is a Healthcare company based in India. Global CRO offers pharmaceutical research, development, and manufacturing support services. It operates on a B2B model. Its Indian entity Intelliscend Nddr Private Limited reported revenue of ₹2.77 Cr. Intelliscend offers products and services including Formulation Support, Analytical Support, Technology Transfer Support, and Bioequivalence Support. Its focus areas include Pharmaceuticals, Technology Transfer, Manufacturing Support and Contract Research.
Company details
Intelliscend, founded in 2014, is a goal-driven global Contract Research Organisation based in Navi Mumbai, India. It provides one-stop solutions for pharmaceutical projects, including development, bioequivalence studies, technology transfer, manufacturing, and regulatory approvals. The company serves clients in over 60 countries with a skilled team and advanced facilities, focusing on dosage forms like tablets and capsules.
- Headquarters India
- SectorsHealthcare
- Website intelliscend.com
- Social LinkedIn
- Legal Name Intelliscend Nddr Private Limited
- Date of Incorporation 01 Apr, 2019
- Jurisdiction Thane, Maharashtra, India
- Annual Revenue₹2.77 Cr
FY 2024 · +131% YoY
- Net Loss-₹26.2 Lakh
FY 2024 · -9% margin
- EBITDA-₹6.6 Lakh
FY 2024 · -2% margin
Associated legal entities of Intelliscend
Intelliscend operates through Intelliscend Nddr Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Intelliscend Nddr Private Limited CIN U24230MH2019PTC323470 | Active | 01 Apr 2019 | Thane, Maharashtra | ₹2.8 Cr | 4 | View details |
Products & Services of Intelliscend
Intelliscend offers a comprehensive portfolio of products and services, including Formulation Support, Analytical Support, Technology Transfer Support, and Bioequivalence Support.
Assists in developing pharmaceutical formulations and dosage forms.
Provides analytical testing for pharmaceutical products.
Facilitates transfer of technology for pharma production.
Offers support for bioequivalence studies in drugs.
Board of directors of Intelliscend Nddr Private Limited (Intelliscend)
Intelliscend Nddr Private Limited is the primary company behind Intelliscend. The board of Intelliscend Nddr Private Limited currently have 4 directors; the longest-serving is Shashank Sunilendu Roy, appointed in 2019. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Shashank Sunilendu Roy DIN 08408134 | Director | 01 Apr 2019 | 7 yrs 6 mo | Intelliscend Nddr Private Limited |
| Sunilendu Bhushan Roy DIN 07449487 | Additional Director | 20 Nov 2019 | 6 yrs 11 mo | Intelliscend Nddr Private Limited |
| Manmohan Padamsingh Negi DIN 08679659 | Additional Director | 25 Jan 2020 | 6 yrs 9 mo | Intelliscend Nddr Private Limited |
| Kalpak Balkrishana Vartak DIN 08639858 | Additional Director | 25 Jan 2020 | 6 yrs 9 mo | Intelliscend Nddr Private Limited |
Financials of Intelliscend
Figures of Intelliscend Nddr Private Limited, the primary company behind Intelliscend, for FY 2024. Revenue was ₹2.77 Cr (+131% year on year). Net loss was -₹26.2 Lakh (-9% margin). EBITDA was -₹6.6 Lakh (-2% margin). Revenue has grown at a compounded annual rate of +23% over three years.
- ₹2.77 CrRevenue · FY 2024 · +131% YoY
- -₹26.2 LakhNet loss · -9% margin
- -₹6.6 LakhEBITDA · -2% margin
- ₹5 LakhPaid-up capital
- +23%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Intelliscend Nddr Private Limited are on its company page.
Detailed financial statements for Intelliscend
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Intelliscend
Intelliscend is headquartered in India.
The primary company behind Intelliscend, Intelliscend Nddr Private Limited, reported revenue of ₹2.77 Cr for FY 2024, up 131% year on year.
Intelliscend, founded in 2014, is a goal-driven global Contract Research Organisation based in Navi Mumbai, India. It provides one-stop solutions for pharmaceutical projects, including development, bioequivalence studies, technology transfer, manufacturing, and regulatory approvals. The company serves clients in over 60 countries with a skilled team and advanced facilities, focusing on dosage forms like tablets and capsules.
Intelliscend offers Formulation Support, Analytical Support, Technology Transfer Support, and Bioequivalence Support.
Intelliscend operates through Intelliscend Nddr Private Limited.
The legal entities of Intelliscend currently have 4 directors, including Manmohan Padamsingh Negi, Kalpak Balkrishana Vartak, Shashank Sunilendu Roy and others.